Asthma control in severe asthma patients treated with tezepelumab: A prospective, observational, real-world evidence study in Europe and Canada (ASCENT)

被引：0
|
作者：
Milger-Kneidinger, Katrin [1 ]
Del Dorscheid [2 ]
Gessner, Christian [3 ]
Sundbom, Fredrik [4 ]
Stolz, Daiana [5 ]
Urbanski, Hannah [6 ]
Le, Tham [7 ]
Emmanuel, Benjamin [7 ]
Tran, Trung [7 ]
Clarke, Deborah
Llanos, Jean-Pierre [8 ,9 ]
Clarke, Nicole [7 ]
Ruckh, Tim [10 ]
Kayaniyil, Sheena [10 ]
Martin, Neil
Stjepanovic, Neda [9 ]
Porsbjerg, Celeste [11 ]
机构：
[1] Ludwig Maximilians Univ Munich LMU, Univ Hosp, Dept Internal Med 5, Munich, Germany
[2] Univ British Columbia, Ctr Heart Lung Innovat, Dept Med, Providence Hlth Care, Vancouver, BC, Canada
[3] Univ Klinikum Leipzig, Germany POIS Leipzig Gb, Leipzig, Germany
[4] Uppsala Univ, Dept Med Sci Resp Allergy & Sleep Res, Uppsala, Sweden
[5] Univ Hosp, Clin Pulm Med & Resp Cell Res, Petersgraben 4, CH-4031 Basel, Switzerland
[6] AstraZeneca, BioPharmaceut Med, Resp & Immunol, Cambridge, England
[7] AstraZeneca, BioPharmaceut Med, Resp & Immunol, Gaithersburg, MD USA
[8] Global Med Affairs, Thousand Oaks, CA USA
[9] AstraZeneca, Resp & Immunol, BioPharmaceut Med, Gothenburg, Sweden
[10] AstraZeneca, Resp & Immunol, BioPharmaceut Med, Mississauga, ON, Canada
[11] Univ Hosp Bispebjerg, Dept Resp Med, Copenhagen, Denmark
来源：
EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷
关键词：
Asthma; -; management;
D O I：
10.1183/13993003.congress-2023.PA4726
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] The Real-world Effectiveness of Tezepelumab in a Cohort of Patients with Severe Asthma
    Nopsopon, Tanawin
    Brown, Alyson
    Akenroye, Ayobami
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB96 - AB96
  • [2] Real-World Data on Tezepelumab in Patients With Severe Asthma in Germany
    Biener, Leonie
    Muemmler, Carlo
    Hinze, Christopher Alexander
    Suhling, Hendrik
    Korn, Stephanie
    Fisser, Christoph
    Biener, Arne
    Pizarro, Carmen
    Lenoir, Alexandra
    Hackl, Caroline
    Skowasch, Dirk
    Milger, Katrin
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2024, 12 (09):
  • [3] A Real-world Experience With Tezepelumab as the First Biologic Option in Severe Asthma Patients
    Mohan, A.
    Bagheri, A.
    Senn, R.
    Harwood, H.
    Fergan, J.
    Derstine, B.
    Lugogo, N. L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [4] Real-world outcomes of mepolizumab for the treatment of severe eosinophilic asthma in Canada: an observational study
    Chapman, Kenneth R.
    Cogger, Kathryn
    Arthurs, Erin
    LaForty, Callahan
    Golden, Shane
    Millson, Bradley
    Usuba, Koyo
    Licskai, Christopher
    ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2024, 20 (01):
  • [5] Real-world outcomes of mepolizumab for the treatment of severe eosinophilic asthma in Canada: an observational study
    Kenneth R. Chapman
    Kathryn Cogger
    Erin Arthurs
    Callahan LaForty
    Shane Golden
    Bradley Millson
    Koyo Usuba
    Christopher Licskai
    Allergy, Asthma & Clinical Immunology, 20
  • [6] Real-World Safety and Effectiveness of Benralizumab in Japanese Patients with Severe Asthma: A Multicenter Prospective Observational Study
    Yamaguchi, Masao
    Nishimura, Yoshihiro
    Takumi, Yuko
    Hayashi, Nobuya
    Sakamoto, Kei
    Tohda, Yuji
    JOURNAL OF ASTHMA AND ALLERGY, 2024, 17 : 45 - 60
  • [7] Real-world Experience With Tezepelumab for Severe Asthma in an Academic Medical Center
    Crowther, L.
    Strome, S.
    Akuthota, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [8] Characteristics by Provider Subspecialty of Patients Enrolled in the CHRONICLE Study: A Real-World, Prospective, Observational Study of US, Subspecialist-Treated Adults with Severe Asthma
    Panettieri, R. A.
    Carr, W.
    Chipps, B. E.
    Ledford, D. K.
    Lugogo, N.
    Moore, W. C.
    Soong, W.
    Trevor, J.
    Belton, L.
    Trudo, F.
    Ambrose, C. S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [9] Omalizumab for Chinese patients with moderate-to-severe allergic asthma in real-world clinical setting: a prospective, observational study
    Wang, Wen
    Li, Jieying
    Zou, Congying
    Zhao, Lifang
    Zhu, Ya
    Guo, Yue
    Wang, Feiran
    BMJ OPEN RESPIRATORY RESEARCH, 2023, 10 (01)
  • [10] A Real-world Experience on New Starts Versus Biological Switchers for Tezepelumab in Severe Asthma
    Mohan, A.
    Senn, R.
    Harwood, H.
    Derstine, B.
    Fergan, J.
    Bagheri, A.
    Lugogo, N. L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
12345